-+ 0.00%
-+ 0.00%
-+ 0.00%

'A Rare Disease Drug Was Approvable, Then It Wasn't. Inside A Surprise Rejection By The FDA; Drugmakers Say Agency's Reasons For Decision Were At Odds With Previous Exchanges' - STAT News

Benzinga·02/25/2026 18:00:47
Listen to the news